Quick Takeaways
- Core Insight: Inventia Healthcare has initiated a nationwide recall of specific lots of Chlorthalidone tablets due to failure in dissolution testing standards.
- Key Highlight: The recall impacts over 13,000 bottles of the antihypertensive medication distributed across the United States.
- Actionable Advice: Patients should verify their prescription bottle lot numbers against the FDA recall list and consult their physician before discontinuing use.
WASHINGTON — Inventia Healthcare Limited has issued a nationwide recall for more than 13,000 bottles of Chlorthalidone tablets, a widely prescribed medication used to treat hypertension and fluid retention. The voluntary recall follows internal testing that revealed the product failed to meet critical FDA dissolution specifications, potentially impacting the drug's efficacy in the bloodstream.
- Inventia Healthcare Chlorthalidone Tablet Recall Scope
- Technical Specifications and Quality Standards
- Understanding Dissolution Failure
- Timeline and Regulatory Response
- Official Outlook and Patient Guidance
- Frequently Asked Questions
- How do I know if my Chlorthalidone is part of the recall?
- Is it safe to continue taking the medication until I get a replacement?
- What should I do with the recalled medication?
Inventia Healthcare Chlorthalidone Tablet Recall Scope
The recall specifically targets 25mg and 50mg tablets distributed by Inventia Healthcare under various labels. Dissolution testing is a mandatory quality control process that ensures a tablet breaks down correctly in the gastrointestinal tract, allowing the active pharmaceutical ingredient to be absorbed at the intended rate. When a medication fails these standards, it risks providing sub-therapeutic doses to patients managing chronic cardiovascular conditions. — Custom Drapes Near Me: Local Artisans Vs. Online Retailers
Regulatory filings indicate the affected batches were distributed to wholesalers and pharmacies across the United States. While no adverse events have been reported to the company as of the latest filing, the FDA classifies this as a Class II recall, meaning the product may cause temporary or medically reversible adverse health consequences. — What's My Number: How To Identify And Protect Your Phone Identity
Technical Specifications and Quality Standards
The following table outlines the technical parameters and the nature of the dissolution failure observed in the recalled inventory. — Craigslist Lafayette LA Vs Local News: Finding Reliable Services
| Parameter | Details / Specs | Recommendation |
|---|---|---|
| Product Name | Chlorthalidone Tablets | Verify lot number on bottle |
| Recall Class | Class II | Do not use if lot matches |
| Failure Mode | Dissolution Testing | Contact pharmacist for replacement |
| Impact | Potential sub-therapeutic delivery | Consult doctor for alternative |
Understanding Dissolution Failure
Dissolution testing serves as a proxy for how a drug performs in the human body. If a tablet fails to dissolve within the specified timeframe, the bioavailability of the drug is compromised. For patients relying on Chlorthalidone to manage blood pressure, a lack of consistent absorption can lead to uncontrolled hypertension, increasing the risk of stroke or myocardial infarction. Manufacturers are required to maintain strict adherence to United States Pharmacopeia (USP) standards to prevent these deviations.
Timeline and Regulatory Response
The FDA identified the quality issue during routine post-market surveillance and internal audit reports provided by Inventia Healthcare. The company began notifying distributors and retailers via urgent recall notices in the current quarter. Pharmacists have been instructed to quarantine any remaining stock of the affected lots and facilitate returns to the manufacturer. Patients who have received medication from these specific batches are being contacted through their respective pharmacy providers to initiate a return or exchange process. — Charles Kelley Cancer Diagnosis: Lady A Singer Shares Health Update
Official Outlook and Patient Guidance
Inventia Healthcare has stated it is working closely with federal regulators to identify the root cause of the manufacturing variance. The company maintains that the recall is a precautionary measure to ensure patient safety and product integrity. Medical professionals advise patients not to stop taking their blood pressure medication abruptly, as sudden cessation can lead to rebound hypertension. Patients should secure a replacement prescription from their healthcare provider before disposing of the recalled medication.
Frequently Asked Questions
How do I know if my Chlorthalidone is part of the recall?
Patients should check the lot number printed on their prescription bottle and compare it against the official recall notice published on the FDA website. If the lot number matches, contact your local pharmacy to confirm if your specific unit is subject to the recall. — Pete Hegseth Midterm Elections Memo Targets Foreign Interference
Is it safe to continue taking the medication until I get a replacement?
Consult your physician or pharmacist immediately before making any changes to your medication regimen. Abruptly stopping blood pressure treatment can cause dangerous spikes in blood pressure, so a replacement plan should be coordinated by a medical professional. — Diddy’s Prison Release Date Set Amid Controversial Reports
What should I do with the recalled medication?
Do not consume the tablets if they are confirmed to be part of the recalled lots. Return the medication to your pharmacy for proper disposal and to ensure you receive a safe, non-recalled replacement product.
Join the conversation. Be respectful and adhere to our community guidelines.